| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |